Prophylaxis of hepatitis B recurrence after liver transplantation with lamivudin and hepatitis B immunoglobulin

被引：7

作者：

Engler, S

Sauer, P

Klar, E

Stremmel, W

Kallinowski, B

机构：

[1] Univ Heidelberg, Dept Med 4, D-69115 Heidelberg, Germany

[2] Univ Heidelberg, Dept Abdominal & Transplant Surg, D-69115 Heidelberg, Germany

来源：

TRANSPLANTATION PROCEEDINGS | 2002年 / 34卷 / 06期

关键词：

D O I：

10.1016/S0041-1345(02)03238-4

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

[No abstract available]

引用

页码：2285 / 2287

页数：3

共 24 条

[1] Combination low-dose hepatitis B immune globulin and lamivudine therapy provides effective prophylaxis against posttransplantation hepatitis B [J].

Angus, PW ;

McCaughan, GW ;

Gane, EJ ;

Crawford, DHG ;

Harley, H .

LIVER TRANSPLANTATION, 2000, 6 (04) :429-433

[2] Efficacy of lamivudine in chronic hepatitis B patients with active viral replication and decompensated cirrhosis undergoing liver transplantation [J].

Bain, VG ;

Kneteman, NM ;

Ma, MM ;

Gutfreund, K ;

Shapiro, JA ;

Fischer, K ;

Tipples, G ;

Lee, H ;

Jewell, LD ;

Tyrrell, DL .

TRANSPLANTATION, 1996, 62 (10) :1456-1462

[3] Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation [J].

Bartholomew, MM ;

Jansen, RW ;

Jeffers, LJ ;

Reddy, KR ;

Johnson, LC ;

Bunzendahl, H ;

Condreay, LD ;

Tzakis, AG ;

Schiff, ER ;

Brown, NA .

LANCET, 1997, 349 (9044) :20-22

[4] Intravenous or intramuscular anti-HBs immunoglobulin for the prevention of hepatitis B reinfection after orthotopic liver transplantation [J].

Burbach, GJ ;

Bienzle, U ;

Neuhaus, R ;

Hopf, U ;

Metzger, WG ;

Pratschke, J ;

Neuhaus, P .

TRANSPLANTATION, 1997, 63 (03) :478-480

[5]

Colquhoun SD, 2000, SEMIN LIVER DIS, V20, P7

[6] A PRELIMINARY TRIAL OF LAMIVUDINE FOR CHRONIC HEPATITIS-B INFECTION [J].

DIENSTAG, JL ;

PERRILLO, RP ;

SCHIFF, ER ;

BARTHOLOMEW, M ;

VICARY, C ;

RUBIN, M .

NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (25) :1657-1661

[7] Hepatitis B virus S mutants in liver transplant recipients who were reinfected despite hepatitis B immune globulin prophylaxis [J].

Ghany, MG ;

Ayola, B ;

Villamil, FG ;

Gish, RG ;

Rojter, S ;

Vierling, JM ;

Lok, ASF .

HEPATOLOGY, 1998, 27 (01) :213-222

[8] Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis [J].

Grellier, L ;

Mutimer, D ;

Ahmed, M ;

Brown, D ;

Burroughs, AK ;

Rolles, K ;

McMaster, P ;

Beranek, P ;

Kennedy, F ;

Kibbler, H ;

McPhillips, P ;

Elias, E ;

Dusheiko, G .

LANCET, 1996, 348 (9036) :1212-1215

[9] An efficacy and cost-effectiveness analysis of combination hepatitis B immune globulin and lamivudine to prevent recurrent hepatitis B after orthotopic liver transplantation compared with hepatitis B immune globulin monotherapy [J].

Han, SHB ;

Ofman, J ;

Holt, C ;

King, K ;

Kunder, G ;

Chen, P ;

Dawson, S ;

Goldstein, L ;

Yersiz, H ;

Farmer, DG ;

Ghobrial, RM ;

Busuttil, RW ;

Martin, P .

LIVER TRANSPLANTATION, 2000, 6 (06) :741-748

[10] Liver transplantation for patients with hepatitis B: Prevention of hepatitis B recurrence by intravenous AntiHepatitis B immunoglobulin and lamivudine [J].

Lee, PH ;

Hu, RH ;

Tsai, MK ;

Ho, MC ;

Lai, HS ;

Lai, MY ;

Yang, PM .

TRANSPLANTATION PROCEEDINGS, 2000, 32 (07) :2245-2247

← 1 2 3 →